首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   33524篇
  免费   2036篇
  国内免费   151篇
医药卫生   35711篇
  2023年   260篇
  2022年   243篇
  2021年   1047篇
  2020年   626篇
  2019年   923篇
  2018年   1122篇
  2017年   750篇
  2016年   883篇
  2015年   1003篇
  2014年   1375篇
  2013年   1785篇
  2012年   2705篇
  2011年   2735篇
  2010年   1463篇
  2009年   1295篇
  2008年   2179篇
  2007年   2223篇
  2006年   2064篇
  2005年   1880篇
  2004年   1691篇
  2003年   1640篇
  2002年   1444篇
  2001年   426篇
  2000年   380篇
  1999年   382篇
  1998年   270篇
  1997年   222篇
  1996年   205篇
  1995年   158篇
  1994年   134篇
  1993年   145篇
  1992年   228篇
  1991年   184篇
  1990年   150篇
  1989年   162篇
  1988年   126篇
  1987年   133篇
  1986年   125篇
  1985年   106篇
  1984年   101篇
  1983年   79篇
  1982年   52篇
  1981年   54篇
  1980年   51篇
  1979年   59篇
  1978年   37篇
  1974年   31篇
  1973年   36篇
  1972年   28篇
  1971年   27篇
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
2.
BackgroundLittle is known about the extent of ordering low-value services by.PurposeTo compare the rates of low-value back images ordered by primary care physicians (PCMDs) and primary care nurse practitioners (PCNPs).MethodWe used 2012 and 2013 Medicare Part B claims for all beneficiaries in 18 hospital referral ?regions (HRRs) and a measure of low-value back imaging from Choosing Wisely. Models included random clinician effect and fixed effects for beneficiary age, disability, Elixhauser comorbidities, clinician sex, the emergency department setting, back pain visit volume, organization, and region (HRR).FindingsPCNPs (N = 231) and PCMDs (N = 4,779) order low-value back images at similar rates (NP: all images: 26.5%; MRI/CT: 8.4%; MD: all images: 24.5%; MRI/CT: 7.7%), with no detectable significant difference when controlling for covariates.DiscussionPCNPs and PCMDs order low-value back images at an effectively similar rate.  相似文献   
3.
4.
5.
6.
7.
8.
Colorectal cancer (CRC) screening programs help diagnose cancer precursors and early cancers and help reduce CRC mortality. However, currently recommended tests, the fecal immunochemical test (FIT) and colonoscopy, have low uptake. There is therefore a pressing need for screening strategies that are minimally invasive and consequently more acceptable to patients, most likely blood based, to increase early CRC identification. MicroRNAs (miRNAs) released from cancer cells are detectable in plasma in a remarkably stable form, making them ideal cancer biomarkers. Using plasma samples from FIT-positive (FIT+) subjects in an Italian CRC screening program, we aimed to identify plasma circulating miRNAs that detect early CRC. miRNAs were initially investigated by quantitative real-time PCR in plasma from 60 FIT+ subjects undergoing colonoscopy at Fondazione IRCCS Istituto Nazionale dei Tumori, then tested on an internal validation cohort (IVC, 201 cases) and finally in a large multicenter prospective series (external validation cohort [EVC], 1121 cases). For each endoscopic lesion (low-grade adenoma [LgA], high-grade adenoma [HgA], cancer lesion [CL]), specific signatures were identified in the IVC and confirmed on the EVC. A two-miRNA-based signature for CL and six-miRNA signatures for LgA and HgA were selected. In a multivariate analysis including sex and age at blood collection, the areas under the receiver operating characteristic curve (95% confidence interval) of the signatures were 0.644 (0.607–0.682), 0.670 (0.626–0.714) and 0.682 (0.580–0.785) for LgA, HgA and CL, respectively. A miRNA-based test could be introduced into the FIT+ workflow of CRC screening programs so as to schedule colonoscopies only for subjects likely to benefit most.  相似文献   
9.
Archives of Gynecology and Obstetrics - The objective of this study was to determine if high-dose antibiotic prophylaxis with cefazolin decreases the risk of surgical site infection (SSI) after a...  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号